Increased Trend of Breast Cancer Mortality in Iran

  • Taghavi, Afsoon (Department of Pathology, Shahid Beheshti University of Medical Sciences) ;
  • Fazeli, Zeinab (Research Center for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences) ;
  • Vahedi, Mohsen (Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences) ;
  • Baghestani, Ahmad Reza (Department of Mathematics, Islamic Azad University) ;
  • Pourhoseingholi, Asma (Research Center for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences) ;
  • Barzegar, Farnoosh (Research Center for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences) ;
  • Pourhoseingholi, Mohamad Amin (Research Center for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences)
  • Published : 2012.01.31


Background: Breast cancer is the most commonly diagnosed cancer in women worldwide In Iran, it ranks first among cancers diagnosed in women and is the fifth most common cause of death. The aim of this study was to present the mortality trends from breast cancer for Iranian women during a period of almost a decade, in order to provide update information regarding the likely future. Methods: We analyzed National death Statistic reported by the Iranian Ministry of Health and Medical Education from 1995 to 2004 to generate annual mortality rates/100,000, overall, by age group (<15, 15-49 and ${\geq}50$ years of age) and age standardized rate (ASR). Results: The age standardized mortality rate of breast cancer increased dramatically during these years from 1.40 to 3.52 per 100,000 and its mortality was increasing 151.4% for Iranian women, although it seemed that the rate leveled off from 2002 to 2004. Moreover the increasing rate was higher for those aged between 15-49 compared to age >50 years old. Conclusion: There is an increasing trend for breast cancer mortality in Iran. Thus, health education programs to rectify the lack of women awareness about breast cancer signs and effective screening are urgently needed.


  1. Ahmad O, Boschi Pinto C, Lopez AD, et al (2001). Age standardization of rates: a new WHO standard. Geneva, World Health Organization.
  2. Akbari ME (2008). Iran cancer report. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Qom: Darolfekr.
  3. Autier P, Boniol M, Gavin A, et al (2011). Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ, 28, 343-?.
  4. Botha JL, Bray F, Sankila R, et al (2003). Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer, 39, 1718-29.
  5. Bulliard JL, La Vecchia C, Levi F (2006). Diverging trends in breast cancer mortality within Switzerland. Ann Oncol, 7, 57-9.
  6. Choi Y, Kim Y, Park SK, et al (2006). Age-Period-Cohort Analysis of Female Breast Cancer Mortality in Korea. Breast Cancer, 13, 266-71.
  7. Das B, Feuer EJ, Mariotto A (2005). Geographic association between mammography use and mortality reduction in the US. Cancer Causes Control, 16, 691-9.
  8. Elmore JG, Armstrong K, Lehman CD, et al (2005). Screening for breast cancer. JAMA, 293, 1245-56.
  9. Forbes JF (1997). The incidence of breast cancer: the global burden, public health considerations. Semin Oncol, 24, 20-35.
  10. Fracheboud J, Otto SJ, Van Dijck JA, et al (2004). Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer, 91, 861-7.
  11. Harirchi I, Ebrahimi M, Zamani N, et al (2000). Breast cancer in Iran: a review of 903 case records. Public Health, 114, 143-5.
  12. Harirchi I, Karbakhsh M, Kashefi A, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5, 24-7.
  13. Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2011). Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol, 22, 93-7.
  14. He M, Guo Q, Hu G (2011). Reversed urban-rural differences in breast cancer mortality (China, 2002-2008). Breast Cancer Res Treat, 126, 231-4.
  15. Hery C, Ferlay JM, Boniol M, et al (2009). Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol, 19, 1187-94.
  16. Hirte L, Nolte E, Bain C, et al (2007). Breast cancer mortality in Russia and Ukraine 1963-2002: an age-period-cohort analysis. Int J Epidemiol, 36, 900-6.
  17. Hoerger TJ, Ekwueme DU, Miller JW, et al (2011). Estimated Effects of the National Breast and Cervical Cancer Early Detection Program on Breast Cancer Mortality. Am J Prev Med, 40, 397-404.
  18. IARC (2002). Globocan 2002 Database. Mortality. Available at http://wwwdep.
  19. IzquierdoA, GispertR, Saladie F, et al (2008). Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: Breast cancer. Med Clin (Barc), 131, 50-2.
  20. Katanoda K, Yako Suketomo H (2010). Comparison of Time Trends in Breast Cancer Mortality (1990-2006) in the World, from the WHO Mortality Database. Jpn J Clin Oncol, 40, 182-?.
  21. Kogevinas M, Pearce N, Susser M, et al (1997). Social inequalities and cancer. Lyon. IARC Scientific Publications no. 138.
  22. Kono A, Misumi J, Misumi J (2005). The time trend of breast cancer mortality in Japan. Arch Gynecol Obstet, 272, 187-90.
  23. Levi F, Bosetti C, Lucchini F, et al (2005). Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev, 14, 497-502.
  24. Marks NF, Shinberg DS (1998). Socioeconomic status differences in hormone therapy. Am J Epidemiol, 148, 581-93.
  25. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, et al (2009). Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998 - 2001. Arch Iran Med, 12, 15-23.
  26. Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med, 7, 6-?.
  27. Moore MA, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pac J Cancer Prev, 11, 17-32.
  28. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  29. Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, et al (2006). Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Asian Pac J Cancer Prev, 7, 571-4.
  30. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91.
  31. Naghavi M (2002). Death report from 18 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
  32. Naghavi M (2003). Death report from 18 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
  33. Naghavi M (2004). Death report from 18 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
  34. Naghavi M, Abolhassani F, Pourmalek F, et al (2003). The burden of disease and injury in Iran 2003. Popul Health Metr, 15, 7-9.
  35. Park SK, Kim Y, Kang D, et al (2011). Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea. J Breast Cancer, 14, 79-87.
  36. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
  37. Parkin DM, Whelan SL, Ferlay J, et al (1997). Cancer incidence in five continents, vol. VII. Lyon. IARC Scientific Publications no. 143.
  38. Sadjadi A, Nouraie M, Mohagheghi MA, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-63.
  39. Shamsa AZ, Mohagheghi MA (2002). Final report of the National project for cancer registry. Islamic Republic of Iran.
  40. Threlfall AG, Collins S, Woodman CB (2003). Impact of NHS breast screening on advanced disease and mortality from breast cancer in the North West of England. Br J Cancer, 89, 77-80.
  41. U.S. Cancer Statistics Working Group (2010). U.S. Cancer Statistics: 2005 Incidence and Mortality. Atlanta GA: USDHHS, CDC and National Cancer Institute,
  42. Wilson CM, Tobin S, Young RC (2004). The exploding worldwide cancer burden: the impact of cancer on women. Int J Gynecol Cancer, 14, 1-11.
  43. World Health Organization (2009). Mortality database. WHO, , 2-6.
  44. World Health Organization: Cancer (2008). []. accessed 30.07.
  45. Yavari P, Pourhoseingholi MA (2007). Socioeconomic factors association with knowledge and practice of breast selfexamination among Iranian women. Asian Pac J Cancer Prev, 8, 618-22.
  46. W, Shu XO, McLaughlin JK, et al (1993). Occupational physical activity and the incidence of cancer of the breast, corpus uteri, and ovary in Shanghai. Cancer, 71, 3620-4.<3620::AID-CNCR2820711125>3.0.CO;2-S

Cited by

  1. Identification of Germline BRCA1 Mutations among Breast Cancer Families in Northeastern Iran vol.14, pp.7, 2013,
  2. Social Disparity in Breast and Ovarian Cancer Incidence in Iran, 2003-2009: A Time Trend Province-Level Study vol.16, pp.4, 2013,
  3. Breast cancer incidence and mortality in women under 50 years of age in Brazil vol.29, pp.11, 2013,
  4. Relationship of Body Mass Index with Prognosis in Breast Cancer Patients Treated with Adjuvant Radiotherapy and Chemotherapy vol.15, pp.10, 2014,
  5. Estimation of the Cure Rate in Iranian Breast Cancer Patients vol.15, pp.12, 2014,
  6. Risk of Cancer with Combined Oral Contraceptive Use among Iranian Women vol.15, pp.14, 2014,
  7. The MMP-2 -735 C Allele is a Risk Factor for Susceptibility to Breast Cancer vol.15, pp.15, 2014,
  8. Exploring Factors Related to Metastasis Free Survival in Breast Cancer Patients Using Bayesian Cure Models vol.15, pp.22, 2014,
  9. Female Breast Cancer Incidence and Mortality in Mexico, 2000-2010 vol.15, pp.3, 2014,
  10. Trends of Breast Cancer Incidence in Iran During 2004-2008: A Bayesian Space-time Model vol.15, pp.4, 2014,
  11. Incidence and Mortality of Female Breast Cancer in Jiangsu, China vol.15, pp.6, 2014,
  12. Health-related quality of life and the predictive role of sense of coherence, spirituality and religious coping in a sample of Iranian women with breast cancer: a prospective study with comparative design vol.13, pp.1, 2015,
  13. The relationship of social support concept and repeat mammography among Iranian women vol.15, pp.1, 2015,
  14. Burden of Breast Cancer in Iranian Women is Increasing vol.16, pp.12, 2015,
  15. Total and Partial Prevalence of Cancer Across Kerman Province, Iran, in 2014, Using an Adapted Generalized Network Scale-Up Method vol.16, pp.13, 2015,
  16. Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines vol.16, pp.14, 2015,
  17. 14-bp Insertion/Deletion Polymorphism of the HLA-G gene in Breast Cancer among Women from North Western Iran vol.16, pp.14, 2015,
  18. Application of a Non-Mixture Cure Rate Model for Analyzing Survival of Patients with Breast Cancer vol.16, pp.16, 2015,
  19. Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center vol.16, pp.17, 2015,
  20. Inhibitory Effects of Cyrtopodion scabrum Extract on Growth of Human Breast and Colorectal Cancer Cells vol.16, pp.2, 2015,
  21. BRCA1 and BRCA2 Common Mutations in Iranian Breast Cancer Patients: a Meta Analysis vol.16, pp.3, 2015,
  22. Role of HER2 in Brain Metastasis of Breast Cancer: a Systematic Review and Meta-Analysis vol.16, pp.4, 2015,
  23. Years of Potential Life Lost and Productivity Costs Due to Premature Cancer-Related Mortality in Iran vol.16, pp.5, 2015,
  24. Vitamin D Receptor Poly(A) Microsatellite Polymorphism and 25-Hydroxyvitamin D Serum Levels: Association with Susceptibility to Breast Cancer vol.18, pp.2, 2015,
  25. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468 vol.26, pp.5, 2015,
  26. -Methylurea-Induced Breast Cancer in Rats vol.34, pp.11, 2015,
  27. Survival Analysis of Patients with Breast Cancer using Weibull Parametric Model vol.16, pp.18, 2016,
  28. Significance of Tissue Expression and Serum Levels of Angiopoietin-like Protein 4 in Breast Cancer Progression: Link to NF-κB /P65 Activity and Pro-Inflammatory Cytokines vol.16, pp.18, 2016,
  29. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors vol.17, pp.1, 2016,
  30. Estimating the Economic Burden of Premature Mortality Caused by Cancer in Iran: 2006-2010 vol.17, pp.4, 2016,
  31. Survival Rates for Breast Cancer in Iranian Patients: a Meta-Analysis vol.17, pp.4, 2016,
  32. Effects of supportive-expressive discussion groups on loneliness, hope and quality of life in breast cancer survivors: a randomized control trial vol.25, pp.9, 2016,
  33. Predictive Factors for Diagnosis and Treatment Delay in Iranian Women with Breast Cancer vol.6, pp.2, 2016,
  34. The antioxidant and chemical properties of Berberis vulgaris and its cytotoxic effect on human breast carcinoma cells vol.68, pp.4, 2016,
  35. Induction of Apoptosis in Human Breast Cancer MCF-7 Cells by a SemiSynthetic Derivative of Artemisinin: A Caspase-Related Mechanism vol.15, pp.3, 2017,
  36. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools vol.8, pp.10, 2017,
  37. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes vol.94, pp.32, 2015,
  38. Predictive Factors for Diagnosis and Treatment Delay in Iranian Women with Breast Cancer vol.In press, pp.In press, 2017,
  39. Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women’s breast cancer tumors vol.70, pp.2, 2018,
  40. Inhibitory Effect of HL-7 and HL-10 Peptides on Human Breast Cancer Cells by Induction of the Expression of Antioxidant Enzymes pp.1573-3904, 2018,
  41. An infodemiology study on breast cancer in Iran vol.36, pp.2, 2018,
  42. Measurement of peripheral dose to the pelvic region and the associated risk for cancer development after breast intraoperative electron radiation therapy vol.39, pp.1, 2019,